CALABRETTA, Bruno

	Titolo	Data di pubblicazione	Autore(i)
1	Wild-type p53 gene expression induces granulocytic differentiation of HL-60 cells.	1994	Soddu S; Blandino G; Citro G; Scardigli R; Piaggio G; Ferber A; Calabretta B; Sacchi A.
2	Wild-type p53 differentially affects tumorigenic and metastatic potential of murine metastatic cell variants.	1993	Rizzo MG; Soddu S; Tibursi G; Calabretta B; Sacchi A.
3	Versatility of BCR/ABL-expressing leukemic cells in circumventing pro-apoptotic BAD effects	2000	P. Salomoni; F. Condorelli; SM Sweeney; B. Calabretta
4	Tumorigenic conversion of p53 deficient colon epithelial cells by an activated Ki-ras gene	1998	SEVIGNANI C; WLODARSKI P; KIRILLOVA J; MERCER WE; DANIELSON KG; IOZZO RV; B. CALABRETTA
5	Tumor induced by Moloney sarcoma virus causes periosteal osteogenesis engaging osteopontin, fibronectin, stromelysin-1 and tenascin.	2007	Wlodarski P; Sevignani C; Fernandes MJ; Calabretta B; Wlodarski KH
6	Treatment of Philadelphia1 leukemia in SCID mice by combination of cyclophosphamide and bcr/abl antisense oligodeoxynucleotides.	1997	Skorski T; Nieborowska-Skorska M; Wlodarski P; Perrotti D; Hoser G; Kawiak J; Majewski M; Christensen L; Iozzo RV; Calabretta B.
7	Translational regulation by the p210 BCR/ABL oncoprotein.	2004	Perrotti D; Calabretta B
8	Transformation of hematopoietic cells by BCR/ABL requires activation of PI-3k/Akt dependent pathway.	1997	Skorski T; Bellacosa A; Nieborowska-Skorska M; Majewski M; Martinez R; Choi JK; Trotta R; Wlodarski P; Perrotti D; Chan TO; Wasik MA; Tsichlis PN; Calabretta B.
9	Transcriptional repression of c-Myb and GATA-2 is involved in the biologic effects of C/EBPalpha in p210BCR/ABL-expressing cells	2008	Soliera AR; Lidonnici MR; Ferrari-Amorotti G; Prisco M; Zhang Y; Martinez RV; Donato NJ; Calabretta B
10	TPA-induction of c-fos mRNA during the cell cycle of WI-38 human fibroblasts.	1987	Calabretta B; Mercer WE.
11	TLS/FUS, a pro-oncogene involved in multiple chromosomal translocations, is a novel regulator of BCR/ABL-mediated leukemogenesis	1998	D. Perrotti; S. Bonatti; R. Trotta; R. Martinez; T. Skorski; P. Salomoni; E. Grassilli; RV Iozzo; DR Cooper; B. Calabretta
12	Tissue specific effects of DR-nm23 and its mutant forms on differentiation and apoptosis of neuroblastoma cells.	2000	Negroni A.; Venturelli D.; Tanno B.; Amendola R.; Cesi V.; Calabretta B.; Raschellà G.
13	The transcription factors c-myb and GATA-2 act independently in the regulation of normal hematopoiesis.	1996	MELOTTI P.; CALABRETTA B.
14	The transcription activation function of C/EBPalpha is required for induction of granulocytic differentiation	2003	K. Keeshan; G. Santilli; F. Corradini; D. Perrotti; B. Calabretta
15	The SH3 domain contributes to BCR/ABL-dependent leukemogenesis in vivo: role in adhesion, invasion, and homing.	1998	Skorski T; Nieborowska-Skorska M; Wlodarski P; Wasik M; Trotta R; Kanakaraj P; Salomoni P; Antonyak M; Martinez R; Majewski M; Wong A; Perussia B; Calabretta B.
16	The role of c-Myc protooncogene in chronic myelogenous leukemia.	1994	Nieborowska-Skórska M; Ratajczak MZ; Calabretta B; Skórski T.
17	The RB-related gene Rb2/p130 in neuroblastoma differentiation and in B-myb promoter down-regulation.	1998	Raschellà G; Tanno B; Bonetto F; Negroni A; Claudio PP; Baldi A; Amendola R; Calabretta B; Giordano A; Paggi MG.
18	The nucleoside diphosphate kinase activity of DRnm23 is not required for inhibition of differentiation and induction of apoptosis in 32Dcl3 myeloid precursor cells.	2000	Venturelli D.; Cesi V.; Ransac S.; Engelhard A.; Perrotti D.; Calabretta B.
19	The Jun family members, c-Jun and JunD, transactivate the human c-myb promoter via an Ap1-like element.	1992	Nicolaides NC; Correa I; Casadevall C; Travali S; Soprano KJ; Calabretta B.
20	The interferon regulatory factors 1 and 2 bind to a segment of the human c-myb first intron: possible role in the regulation of c-myb expression.	2000	Manzella L.; Gualdi R.; Perrotti D.; Nicolaides; N. C.; Girlando G.; Giuffrida; M. A.; Messina A.; Calabretta B.